Literature DB >> 21110290

Low vitamin D levels in Northern American adults with the metabolic syndrome.

S Devaraj1, G Jialal, T Cook, D Siegel, I Jialal.   

Abstract

Metabolic syndrome (MetS), is a constellation of cardiometabolic disease risk factors, that affects 1 in 3 US adults and predisposes to increased risks for both diabetes and cardiovascular disease. While epidemiological studies show low vitamin D [(25(OH)D] levels in MetS, there is sparse data on vitamin D status in MetS patients in North America. Thus, the aim of our study was to examine plasma vitamin D concentration among adults with MetS in Northern California (sunny climate), but without diabetes or cardiovascular disease. 25(OH)D levels were significantly decreased in MetS compared to controls. 8 % of controls and 30% of MetS North American adult subjects were deficient in 25(OH)D (<20 ng/ml; p=0.0236, Controls vs. MetS). There were no significant differences between the groups with respect to blood sampling in winter and summer months, total calcium and phosphate, and creatinine levels. Vitamin D levels were significantly inversely correlated with fasting glucose (r=-0.29, p=0.04) and HOMA (r=-0.34, p=0.04). Future studies of vitamin D supplementation in these subjects on subsequent risk of diabetes will prove instructive with respect to potential health claims in these high risk patients with MetS. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21110290     DOI: 10.1055/s-0030-1268485

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  20 in total

Review 1.  The nonskeletal effects of vitamin D: an Endocrine Society scientific statement.

Authors:  Clifford J Rosen; John S Adams; Daniel D Bikle; Dennis M Black; Marie B Demay; JoAnn E Manson; M Hassan Murad; Christopher S Kovacs
Journal:  Endocr Rev       Date:  2012-05-17       Impact factor: 19.871

2.  The role of vitamin D in the metabolic homeostasis of diabetic bone.

Authors:  Kathryn M Thrailkill; John L Fowlkes
Journal:  Clin Rev Bone Miner Metab       Date:  2013-03-01

Review 3.  Vitamin D safety and requirements.

Authors:  Francisco J A de Paula; Clifford J Rosen
Journal:  Arch Biochem Biophys       Date:  2011-12-09       Impact factor: 4.013

4.  Influence of vitamin D levels on the cardiovascular profile of hypogonadal men.

Authors:  G Tirabassi; M Cutini; G Salvio; G Cerqueni; A Lenzi; G Balercia
Journal:  J Endocrinol Invest       Date:  2017-04-08       Impact factor: 4.256

Review 5.  Is there a relationship between vitamin D with insulin resistance and diabetes mellitus?

Authors:  Kamal As Al-Shoumer; Thamer M Al-Essa
Journal:  World J Diabetes       Date:  2015-07-25

6.  Metabolic syndrome, vitamin D deficiency and hypoadiponectinemia among nondiabetic patients early after kidney transplantation.

Authors:  Satyarth Kulshrestha; Akinlolu O Ojo; Fu L Luan
Journal:  Am J Nephrol       Date:  2013-04-03       Impact factor: 3.754

7.  Gastric dysmotility and low serum vitamin D levels in patients with gastroparesis.

Authors:  A Kedar; Y Nikitina; O R Henry; K B Abell; V Vedanarayanan; M E Griswold; C Subramony; T L Abell
Journal:  Horm Metab Res       Date:  2012-09-06       Impact factor: 2.936

8.  25-Hydroxyvitamin D2 /D3 levels and factors associated with systemic inflammation and melanoma survival in the Leeds Melanoma Cohort.

Authors:  Julia A Newton-Bishop; John R Davies; Faheem Latheef; Juliette Randerson-Moor; May Chan; Jo Gascoyne; Saila Waseem; Susan Haynes; Charles O'Donovan; D Timothy Bishop
Journal:  Int J Cancer       Date:  2014-12-13       Impact factor: 7.396

9.  Is vitamin D status relevant to metabolic syndrome?

Authors:  Barbara J Boucher
Journal:  Dermatoendocrinol       Date:  2012-04-01

Review 10.  Adipose tissue dysfunction in nascent metabolic syndrome.

Authors:  Andrew A Bremer; Ishwarlal Jialal
Journal:  J Obes       Date:  2013-04-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.